Stephen L. Hauser, M.D. is the Robert A. Fishman Distinguished Professor of Neurology at the University of California, San Francisco (UCSF). He is Director of the UCSF Weill Institute for Neurosciences, an umbrella organization that links the clinical and basic neurosciences at UCSF to accelerate research against neurologic diseases. A neuroimmunologist, Dr. Hauser’s research has advanced our understanding of the genetic basis, immune mechanisms, and treatment of multiple sclerosis (MS).

Pam Murnane is an Assistant Professor in the department of Epidemiology & Biostatistics at UCSF. Her research focusses on biological, behavioral, and structural factors that influence maternal and child health outcomes in the context of HIV in resource limited settings. She has expertise in epidemiologic methods, adherence measurement, risk prediction, and implementation science.

I am a physician-scientist who studies and treats infectious diseases. The goal of my laboratory is to discover and exploit molecular vulnerabilities in bacteria in order to design faster, cheaper, less toxic and more effective therapeutics to treat life-threatening infections.

Nooshin Navidi Latour heads communications for the UCSF Bakar Institute for Computational Health Sciences Institute (BCHSI) and UCSF Radiation Oncology. She was formerly the Communications Director for the Vice Chancellor Office for Science Policy and Strategy, and UCSF Precision Medicine. She was in charge of communications and marketing at the UCSF Clinical and Translational Science Institute (CTSI) for several years.

Dr. Krogan was born and raised in Regina, Saskatchewan, Canada, obtained his undergraduate degree from the University of Regina and his PhD from the University of Toronto. Dr. Krogan’s lab at UCSF focuses on developing and applying quantitative, systematic proteomic and genetic approaches to study complex biological and biomedical problems. At present time, the Krogan group is focused on studying cancer, infectious disease and psychiatric disorders.

In the Bondy-Denomy lab, we study CRISPR-Cas bacterial immune systems in an effort to understand their role in antagonizing viruses called bacteriophages. We are very interested in how CRISPR works and the ways that phages inhibit and evade CRISPR-Cas function.